
Sign up to save your podcasts
Or
Drs Sunanda Kane and Peter D. Higgins discuss the first 72 hours of inpatient UC care. What are best practices for diet and painkillers? When should your patient see a surgeon? Tune in to find out.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984006). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Ulcerative Colitis https://emedicine.medscape.com/article/183084-overview
Efficacy and Safety of Biologics and Small Molecule Drugs for Patients With Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Network Meta-analysis https://pubmed.ncbi.nlm.nih.gov/34856198/
Anti-TNF Therapy https://pubmed.ncbi.nlm.nih.gov/27726761/
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy https://pubmed.ncbi.nlm.nih.gov/8196726/
Developing an Instrument to Assess the Endoscopic Severity of Ulcerative Colitis: The Ulcerative Colitis Endoscopic Index of Severity (UCEIS) https://pubmed.ncbi.nlm.nih.gov/21997563/
Fecal Calprotectin https://pubmed.ncbi.nlm.nih.gov/30342711/
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis https://pubmed.ncbi.nlm.nih.gov/30012431/
The Janus Kinases (Jaks) https://pubmed.ncbi.nlm.nih.gov/15575979/
Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis https://pubmed.ncbi.nlm.nih.gov/33319248/
5
33 ratings
Drs Sunanda Kane and Peter D. Higgins discuss the first 72 hours of inpatient UC care. What are best practices for diet and painkillers? When should your patient see a surgeon? Tune in to find out.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984006). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Ulcerative Colitis https://emedicine.medscape.com/article/183084-overview
Efficacy and Safety of Biologics and Small Molecule Drugs for Patients With Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Network Meta-analysis https://pubmed.ncbi.nlm.nih.gov/34856198/
Anti-TNF Therapy https://pubmed.ncbi.nlm.nih.gov/27726761/
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy https://pubmed.ncbi.nlm.nih.gov/8196726/
Developing an Instrument to Assess the Endoscopic Severity of Ulcerative Colitis: The Ulcerative Colitis Endoscopic Index of Severity (UCEIS) https://pubmed.ncbi.nlm.nih.gov/21997563/
Fecal Calprotectin https://pubmed.ncbi.nlm.nih.gov/30342711/
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis https://pubmed.ncbi.nlm.nih.gov/30012431/
The Janus Kinases (Jaks) https://pubmed.ncbi.nlm.nih.gov/15575979/
Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis https://pubmed.ncbi.nlm.nih.gov/33319248/
493 Listeners
111,761 Listeners
9,353 Listeners
4 Listeners